Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.38 |
| ▸ | FDPS | P14324 | 9/20 | 0.37 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8764175 | 0.90 | TSHR (0.38) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL7616020 | 0.89 | TSHR (0.41) | TSHRTHRBFDPS | |
| SCHEMBL25729202 | 0.89 | TSHR (0.46) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL12808397 | 0.88 | TSHR (0.36) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL28081146 | 0.86 | TSHR (0.39) | TSHRTHRBFDPS | |
| SCHEMBL11028136 | 0.86 | LMNA (0.39) | TSHRGGPS1FDPSCES2 | |
| SCHEMBL13696917 | 0.86 | TSHR (0.35) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL25729019 | 0.85 | TSHR (0.43) | TSHRTHRBGGPS1SMPD1 | |
| SCHEMBL5879391 | 0.80 | TSHR (0.38) | TSHR | |
| SCHEMBL11120756 | 0.80 | AKR1B1 (0.48) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2094643-B1 | N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPAN-1-AMINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASES | BRISTOL MYERS SQUIBB CO (US) | 2012-02-29 | — | — | EP | disclosed |